慢性支气管炎呼吸内科规范治疗的效果

刘云英

蓝田县医院，陕西 西安，710500

浏览次数：79次 下载次数：287次

摘要：

目的 分析慢性支气管炎呼吸内科规范治疗的效果。方法 自我院收治的慢性支气管炎患者中筛选符合纳入排除标准的 80例纳入研究范围，以随机数字法将其分为观察组与对照组，每组 40例。对照组给予常规治疗，观察组进行内科规范化治疗。对比两组疗效、病原菌清除情况及不良反应发生率。结果 观察组临床控制率（50.00%）、总有效率（90.00%）、病原菌清除率（92.30%）均高于对照组（25.00% 、72.50% 、68.00%），不良反应总发生率（5.00%）显著低于对照组（20.00%），差异均有统计学意义（P＜0.05）。结论 慢性支气管炎呼吸内科规范治疗可通过对抗感染药物的合理运用，达到有效杀灭病原菌的目的，获得最大的治疗获益。

关键词： 慢性支气管炎；呼吸内科规范治疗；细菌清除率

中图分类号：R562.2文献标志码：A文章编号：2096-1413(2018)09-0042-02

Effects of respiratory medicine standard treatment for chronic bronchitis


LIU Yun-ying
(theHospitalofLantian County,Xi'an 710500,China)




ABSTRACT: Objective To analyze the effects of respiratory medicine standard treatment for chronic bronchitis.Methods Eighty cases of patients with chronic bronchitis in our hospital were selected according to the inclusion and exclusion criteria,and were divided into the observation group and the control group according to random number tablemethod,with 40 cases in each group.The control group was given routine treatment,and the observation group was given the medicine standard treatment.The efficacy,pathogen clearance and the incidence rate of adverse reactions were compared between the two groups.Results The clinical controlrate,total effective rate and pathogen clearance rate(50.00%,90.00% and92.30% )in the observation group were higher than those in the control group (25.00% ,72.50% and68.00% ),and the total incidence rate of adverse reactions in the observation group (5.00% )was significantly lower than that in the control group (20.00% )(P<0.05).Conclusion Respiratory medicine standard treatment for chronic bronchitiscan achieve the purpose ofeffective killing of pathogens through the rationaluseofanti-infectivedrug,andobtaining the great estbenefit of treatment.
KEYWORDS: chronic bronchitis; respiratory medicine standard treatment; bacterial clearance rate

参考文献：
[1]KIM V,CRINER GJ.Thechronic bronchitisphenotype in chronicob structive pulmonary disease:features and implications[J].CurrOpin Pulm Med,2015,21(2):133-141.
[2] 陈一丹,周隽,喻朝宁,等.老年慢性支气管炎合并真菌感染患者的临床治疗 [J].中华医院感染学杂志 ,2016,26(9):1958-1960.
[3] 杨艳平.慢性支气管炎防治指南 [M].北京.人民卫生出版社 ,1999:68-74.
[4] 郑筱萸.中药新药临床研究指导原则:试行 [M]. 北京.中国医药科技出版社 ,2002:54-58.
[5] 陈伟伟,雷励,党惠娇,等.慢性支气管炎患者下呼吸道感染病原菌分布及耐药性分析 [J]. 现代生物医学进展 ,2015,15(19):3683-3685.
[6] 迟岩,怀丽梅,赵鑫亮.老年慢性支气管炎呼吸道感染病原菌分布特点 [J].中国病原生物学杂志 ,2016,11(12):1137-1139.
[7] 郭英,社区老年慢性支气管炎病原菌分布及耐药状况调查研究 [J].实用临床医药杂志 ,2016,20(15):151-152.